Travere Therapeutics Stock Forecast - Relative Strength Index

TVTX Stock  USD 19.37  0.01  0.05%   
Travere Stock Forecast is based on your current time horizon.
  
At this time, Travere Therapeutics' Payables Turnover is fairly stable compared to the past year. Asset Turnover is likely to rise to 0.21 in 2024, whereas Inventory Turnover is likely to drop 0.78 in 2024. . Common Stock Shares Outstanding is likely to drop to about 45.7 M in 2024. Net Loss is likely to rise to about (238.1 M) in 2024.

Open Interest Against 2024-12-20 Travere Option Contracts

Although open interest is a measure utilized in the options markets, it could be used to forecast Travere Therapeutics' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Travere Therapeutics' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Travere Therapeutics stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Travere Therapeutics' open interest, investors have to compare it to Travere Therapeutics' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Travere Therapeutics is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Travere. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Travere Therapeutics has current Relative Strength Index of 48.87.
Check Travere Therapeutics VolatilityBacktest Travere TherapeuticsInformation Ratio  

Travere Therapeutics Trading Date Momentum

On December 04 2024 Travere Therapeutics was traded for  19.37  at the closing time. The top price for the day was 19.75  and the lowest listed price was  19.18 . The trading volume for the day was 717.9 K. The trading history from December 4, 2024 did not result in any price rise and fall. The trading price change against the current closing price is 0.93% .
Compare Travere Therapeutics to competition

Other Forecasting Options for Travere Therapeutics

For every potential investor in Travere, whether a beginner or expert, Travere Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Travere Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Travere. Basic forecasting techniques help filter out the noise by identifying Travere Therapeutics' price trends.

View Travere Therapeutics Related Equities

 Risk & Return  Correlation

Travere Therapeutics Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Travere Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Travere Therapeutics' current price.

Travere Therapeutics Market Strength Events

Market strength indicators help investors to evaluate how Travere Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Travere Therapeutics shares will generate the highest return on investment. By undertsting and applying Travere Therapeutics stock market strength indicators, traders can identify Travere Therapeutics entry and exit signals to maximize returns.

Travere Therapeutics Risk Indicators

The analysis of Travere Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Travere Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting travere stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Travere Stock Analysis

When running Travere Therapeutics' price analysis, check to measure Travere Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Travere Therapeutics is operating at the current time. Most of Travere Therapeutics' value examination focuses on studying past and present price action to predict the probability of Travere Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Travere Therapeutics' price. Additionally, you may evaluate how the addition of Travere Therapeutics to your portfolios can decrease your overall portfolio volatility.